Hi guys,I am surprised by the market reaction today, especially...

Hi guys,

I am surprised by the market reaction today, especially considering it was a reasonably good news.

I found a reliable article showing Herceptin+chemo & Chemotherapy (cisplatin):

https://www.nice.org.uk/guidance/ta208/chapter/3-the-manufacturers-submission

If you jump to Section 3.7, the response rate is shown there. Comparing with our results, & adding data from MoneyMozart (thanks MM) we get:

Her-vaxx + chemo = 50% response rate

Herceptin + chemo = 47.3% response rate

Chemo alone = 34.5 % response rate

Herceptin alone = 15.3 % response rate

So our results (note this is only Ph1b) today showed that Her-Vaxx+chemo works as good as Herceptin+chemo & better than the gold standard chemo alone. Plus we have more safety & tolerability and less side effects compared to Herceptin & chemo. Considering Her-vaxx treatment is significantly cheaper than Herceptin this should be a win for us.

Well, maybe the market needs time to digest the results & experts to interpret them.

Cheers & GLTA